APO Research
Talk to an analyst

APO RESEARCH · REPORT

Solid Dosage Form Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Solid Dosage Form Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchSolid Dosage Form Drug Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Solid Dosage Form Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Solid Dosage Form Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Solid Dosage Form Drug Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Solid Dosage Form Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Solid Dosage Form Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Solid Dosage Form Drug include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Roche, Eli Lilly & Co., Pfizer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Solid Dosage Form Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Solid Dosage Form Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Solid Dosage Form Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Solid Dosage Form Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Solid Dosage Form Drug Segment by Company

Takeda

Teva

Sanofi

Johnson & Johnson

Novartis

Roche

Eli Lilly & Co.

Pfizer

GlaxoSmithKline

Biogen

Bayer

Bristol Myers Squibb

Amgen

AbbVie

AstraZeneca

Merck & Co.

Gilead Sciences

Boehringer Ingelheim

Astellas

Solid Dosage Form Drug Segment by Type

Tablet

Capsules

Other

Solid Dosage Form Drug Segment by Application

Hospital

Retail Pharmacy

Other

Solid Dosage Form Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Dosage Form Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Solid Dosage Form Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solid Dosage Form Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Solid Dosage Form Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Solid Dosage Form Drug industry.

Chapter 3: Detailed analysis of Solid Dosage Form Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Solid Dosage Form Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Solid Dosage Form Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tablet Table 3. Key Players of Capsules Table 4. Key Players of Other Table 4. Global Solid Dosage Form Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Solid Dosage Form Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Solid Dosage Form Drug Market Share by Region (2021-2026) Table 11. Global Solid Dosage Form Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Solid Dosage Form Drug Market Share by Region (2027-2032) Table 13. Solid Dosage Form Drug Industry Trends Table 14. Solid Dosage Form Drug Industry Drivers Table 15. Solid Dosage Form Drug Industry Opportunities and Challenges Table 16. Solid Dosage Form Drug Industry Restraints Table 17. Global Solid Dosage Form Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Solid Dosage Form Drug Revenue Market Share by Company (2021-2026) Table 19. Global Solid Dosage Form Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Solid Dosage Form Drug Key Company Head Office and Area Served Table 21. Global Solid Dosage Form Drug Company, Product Type & Application Table 22. Global Solid Dosage Form Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Solid Dosage Form Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Solid Dosage Form Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Solid Dosage Form Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Solid Dosage Form Drug Revenue Market Share by Type (2021-2026) Table 29. Global Solid Dosage Form Drug Revenue Market Share by Type (2027-2032) Table 30. Global Solid Dosage Form Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Solid Dosage Form Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Solid Dosage Form Drug Revenue Market Share by Application (2021-2026) Table 34. Global Solid Dosage Form Drug Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Solid Dosage Form Drug Product Portfolio Table 39. Takeda Recent Development Table 40. Teva Company Information Table 41. Teva Business Overview Table 42. Teva Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Solid Dosage Form Drug Product Portfolio Table 44. Teva Recent Development Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sanofi Solid Dosage Form Drug Product Portfolio Table 49. Sanofi Recent Development Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Johnson & Johnson Solid Dosage Form Drug Product Portfolio Table 54. Johnson & Johnson Recent Development Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis Solid Dosage Form Drug Product Portfolio Table 59. Novartis Recent Development Table 60. Roche Company Information Table 61. Roche Business Overview Table 62. Roche Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Roche Solid Dosage Form Drug Product Portfolio Table 64. Roche Recent Development Table 65. Eli Lilly & Co. Company Information Table 66. Eli Lilly & Co. Business Overview Table 67. Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Eli Lilly & Co. Solid Dosage Form Drug Product Portfolio Table 69. Eli Lilly & Co. Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pfizer Solid Dosage Form Drug Product Portfolio Table 74. Pfizer Recent Development Table 75. GlaxoSmithKline Company Information Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. GlaxoSmithKline Solid Dosage Form Drug Product Portfolio Table 79. GlaxoSmithKline Recent Development Table 80. Biogen Company Information Table 81. Biogen Business Overview Table 82. Biogen Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Biogen Solid Dosage Form Drug Product Portfolio Table 84. Biogen Recent Development Table 85. Bayer Company Information Table 86. Bayer Business Overview Table 87. Bayer Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Bayer Solid Dosage Form Drug Product Portfolio Table 89. Bayer Recent Development Table 90. Bristol Myers Squibb Company Information Table 91. Bristol Myers Squibb Business Overview Table 92. Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bristol Myers Squibb Solid Dosage Form Drug Product Portfolio Table 94. Bristol Myers Squibb Recent Development Table 95. Amgen Company Information Table 96. Amgen Business Overview Table 97. Amgen Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Amgen Solid Dosage Form Drug Product Portfolio Table 99. Amgen Recent Development Table 100. AbbVie Company Information Table 101. AbbVie Business Overview Table 102. AbbVie Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. AbbVie Solid Dosage Form Drug Product Portfolio Table 104. AbbVie Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. AstraZeneca Solid Dosage Form Drug Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Merck & Co. Company Information Table 111. Merck & Co. Business Overview Table 112. Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Merck & Co. Solid Dosage Form Drug Product Portfolio Table 114. Merck & Co. Recent Development Table 115. Gilead Sciences Company Information Table 116. Gilead Sciences Business Overview Table 117. Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Gilead Sciences Solid Dosage Form Drug Product Portfolio Table 119. Gilead Sciences Recent Development Table 120. Boehringer Ingelheim Company Information Table 121. Boehringer Ingelheim Business Overview Table 122. Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Boehringer Ingelheim Solid Dosage Form Drug Product Portfolio Table 124. Boehringer Ingelheim Recent Development Table 125. Astellas Company Information Table 126. Astellas Business Overview Table 127. Astellas Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Astellas Solid Dosage Form Drug Product Portfolio Table 129. Astellas Recent Development Table 130. North America Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 131. North America Solid Dosage Form Drug Market Size by Type (2027-2032) & (US$ Million) Table 132. North America Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 133. North America Solid Dosage Form Drug Market Size by Application (2027-2032) & (US$ Million) Table 134. North America Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Solid Dosage Form Drug Market Size by Country (2021-2026) Table 136. North America Solid Dosage Form Drug Market Size by Country (2027-2032) Table 137. Europe Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 138. Europe Solid Dosage Form Drug Market Size by Type (2027-2032) & (US$ Million) Table 139. Europe Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 140. Europe Solid Dosage Form Drug Market Size by Application (2027-2032) & (US$ Million) Table 141. Europe Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Solid Dosage Form Drug Market Size by Country (2021-2026) Table 143. Europe Solid Dosage Form Drug Market Size by Country (2027-2032) Table 144. China Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 145. China Solid Dosage Form Drug Market Size by Type (2027-2032) & (US$ Million) Table 146. China Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 147. China Solid Dosage Form Drug Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 149. Asia Solid Dosage Form Drug Market Size by Type (2027-2032) & (US$ Million) Table 150. Asia Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 151. Asia Solid Dosage Form Drug Market Size by Application (2027-2032) & (US$ Million) Table 152. Asia Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Solid Dosage Form Drug Market Size by Country (2021-2026) Table 154. Asia Solid Dosage Form Drug Market Size by Country (2027-2032) Table 155. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 156. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Type (2027-2032) & (US$ Million) Table 157. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 158. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Application (2027-2032) & (US$ Million) Table 159. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country (2021-2026) Table 161. South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Solid Dosage Form Drug Product Image Figure 2. Global Solid Dosage Form Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Solid Dosage Form Drug Market Share by Type: 2025 VS 2032 Figure 4. Tablet Image Figure 5. Capsules Image Figure 6. Other Image Figure 7. Global Solid Dosage Form Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Solid Dosage Form Drug Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Retail Pharmacy Image Figure 11. Other Image Figure 12. Global Solid Dosage Form Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Solid Dosage Form Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Solid Dosage Form Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Solid Dosage Form Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Solid Dosage Form Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Solid Dosage Form Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Solid Dosage Form Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Solid Dosage Form Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Solid Dosage Form Drug Market Share by Type (2021-2032) Figure 25. North America Solid Dosage Form Drug Market Share by Application (2021-2032) Figure 26. North America Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 27. United States Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Solid Dosage Form Drug Market Share by Type (2021-2032) Figure 32. Europe Solid Dosage Form Drug Market Share by Application (2021-2032) Figure 33. Europe Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 34. Germany Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Solid Dosage Form Drug Market Share by Type (2021-2032) Figure 42. China Solid Dosage Form Drug Market Share by Application (2021-2032) Figure 43. Asia Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Solid Dosage Form Drug Market Share by Type (2021-2032) Figure 45. Asia Solid Dosage Form Drug Market Share by Application (2021-2032) Figure 46. Asia Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 47. Japan Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Solid Dosage Form Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Solid Dosage Form Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 57. Brazil Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsules
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Roche
  • Eli Lilly & Co.
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Bayer
  • Bristol Myers Squibb
  • Amgen
  • AbbVie
  • AstraZeneca
  • Merck & Co.
  • Gilead Sciences
  • Boehringer Ingelheim
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Solid Dosage Form Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Capsules
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Solid Dosage Form Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Retail Pharmacy
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Solid Dosage Form Drug Growth Trends by Region
  14. 1.5.1 Global Solid Dosage Form Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Solid Dosage Form Drug Market Size by Region (2021-2026)
  16. 1.5.3 Solid Dosage Form Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Solid Dosage Form Drug Market Dynamics
  1. 2.1 Solid Dosage Form Drug Industry Trends
  2. 2.2 Solid Dosage Form Drug Industry Drivers
  3. 2.3 Solid Dosage Form Drug Industry Opportunities and Challenges
  4. 2.4 Solid Dosage Form Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Solid Dosage Form Drug Revenue by Company (2021-2026)
  2. 3.2 Global Solid Dosage Form Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Solid Dosage Form Drug Key Company Head office and Area Served
  4. 3.4 Global Solid Dosage Form Drug Company, Product Type & Application
  5. 3.5 Global Solid Dosage Form Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Solid Dosage Form Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Solid Dosage Form Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Solid Dosage Form Drug Tier 1, Tier 2, and Tier 3
4 Solid Dosage Form Drug Market by Type
  1. 4.1 Global Solid Dosage Form Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Solid Dosage Form Drug Market Size by Type (2021-2032)
  3. 4.3 Global Solid Dosage Form Drug Market Size Share by Type (2021-2032)
5 Solid Dosage Form Drug Market by Application
  1. 5.1 Global Solid Dosage Form Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Solid Dosage Form Drug Market Size by Application (2021-2032)
  3. 5.3 Global Solid Dosage Form Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Solid Dosage Form Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Solid Dosage Form Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sanofi Solid Dosage Form Drug Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Johnson & Johnson Solid Dosage Form Drug Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Solid Dosage Form Drug Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Roche Solid Dosage Form Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Eli Lilly & Co.
  38. 6.7.1 Eli Lilly & Co. Company Information
  39. 6.7.2 Eli Lilly & Co. Business Overview
  40. 6.7.3 Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eli Lilly & Co. Solid Dosage Form Drug Product Portfolio
  42. 6.7.5 Eli Lilly & Co. Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pfizer Solid Dosage Form Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GlaxoSmithKline Solid Dosage Form Drug Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Biogen
  56. 6.10.1 Biogen Company Information
  57. 6.10.2 Biogen Business Overview
  58. 6.10.3 Biogen Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Biogen Solid Dosage Form Drug Product Portfolio
  60. 6.10.5 Biogen Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer Solid Dosage Form Drug Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 Bristol Myers Squibb
  68. 6.12.1 Bristol Myers Squibb Company Information
  69. 6.12.2 Bristol Myers Squibb Business Overview
  70. 6.12.3 Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bristol Myers Squibb Solid Dosage Form Drug Product Portfolio
  72. 6.12.5 Bristol Myers Squibb Recent Developments
  73. 6.13 Amgen
  74. 6.13.1 Amgen Company Information
  75. 6.13.2 Amgen Business Overview
  76. 6.13.3 Amgen Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Amgen Solid Dosage Form Drug Product Portfolio
  78. 6.13.5 Amgen Recent Developments
  79. 6.14 AbbVie
  80. 6.14.1 AbbVie Company Information
  81. 6.14.2 AbbVie Business Overview
  82. 6.14.3 AbbVie Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AbbVie Solid Dosage Form Drug Product Portfolio
  84. 6.14.5 AbbVie Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 AstraZeneca Solid Dosage Form Drug Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
  91. 6.16 Merck & Co.
  92. 6.16.1 Merck & Co. Company Information
  93. 6.16.2 Merck & Co. Business Overview
  94. 6.16.3 Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Merck & Co. Solid Dosage Form Drug Product Portfolio
  96. 6.16.5 Merck & Co. Recent Developments
  97. 6.17 Gilead Sciences
  98. 6.17.1 Gilead Sciences Company Information
  99. 6.17.2 Gilead Sciences Business Overview
  100. 6.17.3 Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Gilead Sciences Solid Dosage Form Drug Product Portfolio
  102. 6.17.5 Gilead Sciences Recent Developments
  103. 6.18 Boehringer Ingelheim
  104. 6.18.1 Boehringer Ingelheim Company Information
  105. 6.18.2 Boehringer Ingelheim Business Overview
  106. 6.18.3 Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Solid Dosage Form Drug Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Recent Developments
  109. 6.19 Astellas
  110. 6.19.1 Astellas Company Information
  111. 6.19.2 Astellas Business Overview
  112. 6.19.3 Astellas Solid Dosage Form Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Astellas Solid Dosage Form Drug Product Portfolio
  114. 6.19.5 Astellas Recent Developments
7 North America
  1. 7.1 North America Solid Dosage Form Drug Market Size (2021-2032)
  2. 7.2 North America Solid Dosage Form Drug Market Size by Type
  3. 7.2.1 North America Solid Dosage Form Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Solid Dosage Form Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Solid Dosage Form Drug Market Share by Type (2021-2032)
  6. 7.3 North America Solid Dosage Form Drug Market Size by Application
  7. 7.3.1 North America Solid Dosage Form Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Solid Dosage Form Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Solid Dosage Form Drug Market Share by Application (2021-2032)
  10. 7.4 North America Solid Dosage Form Drug Market Size by Country
  11. 7.4.1 North America Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Solid Dosage Form Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Solid Dosage Form Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Solid Dosage Form Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Solid Dosage Form Drug Market Size (2021-2032)
  2. 8.2 Europe Solid Dosage Form Drug Market Size by Type
  3. 8.2.1 Europe Solid Dosage Form Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Solid Dosage Form Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Solid Dosage Form Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Solid Dosage Form Drug Market Size by Application
  7. 8.3.1 Europe Solid Dosage Form Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Solid Dosage Form Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Solid Dosage Form Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Solid Dosage Form Drug Market Size by Country
  11. 8.4.1 Europe Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Solid Dosage Form Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Solid Dosage Form Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Solid Dosage Form Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Solid Dosage Form Drug Market Size (2021-2032)
  2. 9.2 China Solid Dosage Form Drug Market Size by Type
  3. 9.2.1 China Solid Dosage Form Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Solid Dosage Form Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Solid Dosage Form Drug Market Share by Type (2021-2032)
  6. 9.3 China Solid Dosage Form Drug Market Size by Application
  7. 9.3.1 China Solid Dosage Form Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Solid Dosage Form Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Solid Dosage Form Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Solid Dosage Form Drug Market Size (2021-2032)
  2. 10.2 Asia Solid Dosage Form Drug Market Size by Type
  3. 10.2.1 Asia Solid Dosage Form Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Solid Dosage Form Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Solid Dosage Form Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Solid Dosage Form Drug Market Size by Application
  7. 10.3.1 Asia Solid Dosage Form Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Solid Dosage Form Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Solid Dosage Form Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Solid Dosage Form Drug Market Size by Country
  11. 10.4.1 Asia Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Solid Dosage Form Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Solid Dosage Form Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Solid Dosage Form Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Solid Dosage Form Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Solid Dosage Form Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Solid Dosage Form Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Solid Dosage Form Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Solid Dosage Form Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst